文献速递抗栓抗凝管理

性别对香豆素类口服抗凝治疗范围内时间影响的系统评价与荟萃分析

Sex-influence on the time in therapeutic range (TTR) during oral anticoagulation with coumarin derivatives: Systematic review and meta-analysis.
PubMed 文献 · Br J Clin Pharmacol · 2021-05-26

荟萃分析显示,女性与较低TTR相关:二分类变量OR=0.87(95%CI 0.78-0.96;I2=67%),连续变量MD=-2.97(95%CI -4.80至-1.14;I2=75%)。结论提示女性性别与更差的口服抗凝控制相关。

要点

  • 女性与香豆素类抗凝治疗TTR较低独立相关。
  • 二分类TTR的OR=0.87,连续TTR的MD=-2.97。
  • 需针对女性健康设计前瞻性研究及改善策略。

核心结论

  • 女性性别与香豆素类衍生物口服抗凝控制较差(TTR较低)相关。

研究设计与样本

  • 系统评价与荟萃分析,检索MEDLINE、BVS、CINAHL、EMBASE、Cochrane Central和Web of Science。
  • 纳入观察性或实验性研究,年龄≥18岁,两性均包括,使用任何香豆素衍生物≥3个月,长期使用任何适应症,以TTR衡量口服抗凝质量。
  • 主要抗凝适应症为心房颤动,多数研究报告使用华法林。
  • 采用随机效应模型(DerSimonian and Laird)计算二分类变量的比值比(OR)和连续变量的均数差(MD),均报告95%CI。

主要发现

  • 合并估计表明女性与低于男性的TTR相关。

临床怎么用

  • 临床使用香豆素类抗凝药时,应关注女性患者TTR可能较低,加强抗凝管理与监测。
  • 可考虑针对女性健康的创新策略以改善以患者为中心的照护。

局限性

  • 需要主要设计的前瞻性研究探讨影响香豆素类抗凝控制的性别相关因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: We sought to investigate the association between sex and oral anticoagulation control employing coumarin derivatives. METHODS: Electronic sources were MEDLINE, Biblioteca Virtual em Saúde (BVS), The Cumulative Index to Nursing and Allied Health Literature (CINAHL), EMBASE, Cochrane Central and Web of Science. Inclusion criteria were: observational and experimental studies; age ≥18 years; both sexes; treatment with any coumarin derivative for ≥3 months; any indication of long-term use; quality of oral anticoagulation measured by time in therapeutic range (TTR). The meta-analysis was developed with odds ratios (OR) for binary variables and mean differences (MD) for continuous variables, using random-effects models (DerSimonian and Laird) with 95% confidence intervals (CI). RESULTS: Overall, 22 articles were selected, comprising 16 cohort studies, four cross-sectional studies and two clinical trials. The number of participants ranged from 110 to 104 505 (183 612; women: 45%). The main indication of oral anticoagulation was atrial fibrillation. Most studies reported the use of warfarin. In the meta-analysis, 15 studies were analysed using TTR as a binary variable (OR = 0.87; 95% CI = 0.78, 0.96; z = -2.75; P = .006.; I2 = 67%) and seven studies as a continuous variable (MD = -2.97; 95% CI = -4.80, -1.14; z = -3.19; P = .0014; I2 = 75%). The pooled estimates indicated that women were associated with lower TTR than men. CONCLUSIONS: Our findings revealed an association between female sex and worse oral anticoagulation control. Further studies are needed with primary design to investigate sex-related factors influencing oral anticoagulation control with coumarin derivatives. Innovative strategies focused on women's health may be useful to improve patient-centred care.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Costa Viana C, da Silva Praxedes MF, Freitas Nunes de Sousa WJ, et al. Sex-influence on the time in therapeutic range (TTR) during oral anticoagulation with coumarin derivatives: Systematic review and meta-analysis. Br J Clin Pharmacol. 2021. PMID: 33973668. doi:10.1111/bcp.14892

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。